Next Article in Journal
Diagrams as Heuristic Tools. A Semiotic Investigation to Provide a Theoretical Model for the Design of Diagrams
Previous Article in Journal
Screening of Onosma Species for Cytotoxic Activity
Article Menu

Article Versions

Export Article

Open AccessAbstract
Proceedings 2017, 1(10), 1046; doi:10.3390/proceedings1101046

The Effects of Benzoxasol Derivate Compounds in Breast Cancer Cells

1
Faculty of Health Science, Celal Bayar University, Manisa 45000, Turkey
2
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, Ankara 06560, Turkey
3
Department of Pharmacology, Medical of Faculty, Celal Bayar University, Manisa 45000, Turkey
4
Department of Histology and Embryology, Medical of Faculty, Celal Bayar University, Manisa 45000,Turkey
Presented at the 2nd International Conference on Natural Products for Cancer Prevention and Therapy, Kayseri, Turkey, 8–11 November 2017.
*
Author to whom correspondence should be addressed.
Published: 17 November 2017
Download PDF [145 KB, uploaded 17 November 2017]

Abstract

Breast cancer today is the most frequent cancer among women, and the second most common cause of cancer deaths among women. The aim of this study was to synthesize a new benzoxazole derivative, scan it for anti-cancer potential by MTT test using different breast cancer cell lines, and examine its effects on NF-κB and apoptosis related proteins by the western blot method. A newly synthesized benzoxazole derived compound was applied to cancer cell lines and its cytotoxicity was measured quantitatively by MTT test. Later, the level of its effects on NF-κB and apoptosis related proteins were examined. The structure of the compound synthesized in our study (5-amino-2-(p-bromobenzyl) benzoxazoleand 5-[4-chlorobutanamido]-2-(p-methylphenyl) benzoxazole were proved by elemental analysis. In the assay of the proteins by western, when heterocyclic compounds were added to the MDA and MCF-7 cell line, there was no difference from the control group in Apaf-1 and BCL-2 levels, but a reduction was observed in caspase and Nfkβ levels compared with the control group. It is seen that this newly synthesized heterocyclic compound increases apoptosis by reducing the activation of Nfkβ, and in this way has shown an effect of inhibiting tumor growth in cancer treatment.
Keywords: Heterocyclic compounds; NF-κB; APAF-1; cytochrome C; Caspase 3; BCL-2 Heterocyclic compounds; NF-κB; APAF-1; cytochrome C; Caspase 3; BCL-2
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Kosova, F.; Temiz-Arpacı, Ö.; Ölmez, E.; Tuğlu, İ. The Effects of Benzoxasol Derivate Compounds in Breast Cancer Cells. Proceedings 2017, 1, 1046.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Proceedings EISSN 2504-3900 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top